None listed
Conditions
Interventions
Intervention1: Cureit: 500mg capsule once daily
Control Intervention1: Placebo: Capsule 500mg once daily
Sponsors
Plant Lipids P limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: more than 20 years 2. Subjects will be healthy, moderately active (regular aerobic exercise for at least 4 hours per week), non-smoking volunteers with no known musculoskeletal pathology. 3. Subjects should have a maximal oxygen consumption (VO2max) of at least 35 ml/kg, as assessed by the maximal treadmill exercise test. 4. Subjects willing to sign an informed consent and adhere to all protocol requirements.
Exclusion criteria
Exclusion criteria: 1. Treatment with anti-inflammatory/analgesic/antioxidant drugs in the previous month, 2. Abnormal liver or renal function tests, laboratory findings suggestive of an active inflammatory or infectious process and presence of any known disease. 3. Pregnancy or breast feeding 4. Current alcoholism or drug abuse 5. Allergies to one of the component substances in the trial 6. medication (active medication) 7. Participation in another clinical trial less than 3 months previously.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of herbal preparation in patients with Delayed onset muscle soreness (DOMS) due to eccentric muscle activity. Timepoint: Screening visit - day-7 day1 day2 day3 and day4 | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the safety of herbal preparation in patients with Delayed onset muscle soreness (DOMS) due to eccentric muscle activity. Timepoint: Screening visit - day-7 day1 day2 day3 and day4 | — |
Countries
India
Contacts
Public ContactDivya C
BioAgile Therapeutics Pvt Ltd
Outcome results
None listed